Altered cortical excitation-inhibition (E-I) balance resulting from abnormal parvalbumin 3 interneuron (PV IN) function is a proposed pathophysiological mechanism of schizophrenia (SZ) 4 and other major psychiatric disorders. Preclinical studies have indicated that disrupted-in-5 schizophrenia-1 (DISC1) is a useful molecular lead to address the biology of prefrontal cortex 6 dependent cognition and PV IN function. To date, prefrontal cortical inhibitory circuit function 7 has not been investigated in depth in Disc1 locus impairment (LI) mouse models. Therefore, we 8 used a Disc1 LI mouse model to investigate E-I balance in medial prefrontal cortical (mPFC) 9 circuits. We found that inhibition onto layer 3 excitatory pyramidal neurons in the mPFC was 10 significantly reduced in Disc1 LI mice. This reduced inhibition was accompanied by decreased 11 GABA release from local PV, but not somatostatin (SOM) interneurons, and by impaired 12 feedforward inhibition in the mediodorsal thalamus (MD) to mPFC circuit. Our mechanistic 13 findings of abnormal PV IN function in a Disc1 LI model provide insight into biology that may be 14 relevant to neuropsychiatric disorders including schizophrenia. 15
is a potential pathophysiological mechanism of particular relevance to cognitive symptoms of 35 neuropsychiatric diseases, including schizophrenia. Cognitive impairment is seen in first-degree 36 relatives of individuals with a range of major mental illnesses (Cannon et al., 2000; Myles-37 Worsley and Park, 2002; Snitz et al., 2006) , suggesting that these processes are partly heritable 38 and may be better understood through investigation of promising genetic and molecular leads. 39 A translocation in the gene disrupted-in-schizophrenia-1 (Disc1) was first reported in a 40 Scottish pedigree, as a rare but penetrant genetic risk factor that may account for a wide range 41 of major mental illnesses such as depression and schizophrenia (Millar et al., 2000) . This 42 suggests that biological pathway(s) involving the multifunctional hub protein DISC1 contribute to 43 cognitive and behavioral dimensions that are disrupted in neuropsychiatric illnesses (Niwa et al, 44 2016). While DISC1 is not a common genetic variant associated with schizophrenia in large 45 population samples (Schizophrenia Working Group of the Psychiatric Genomics, 2014), it can 46 serve as a molecular lead to study the biology underlying important constructs/dimensions that 47 are relevant to major mental illness (Niwa et al., 2016) . Work in mouse models has revealed the 48 importance of DISC1 in neurodevelopment (Kamiya et Wei et al., 2015) , and cognitive processing (Brandon and Sawa, 2011) . WM impairments are 52 consistently reported across Disc1 mouse models (Koike et al., 2006; Clapcote et al., 2007; Li et 53 5 Adeno-associated virus (AAV) vectors AAV-CAG-ChR2(H134R)-YFP and AAV-eF1a- ChR2(H134R)-YFP were produced as AAV2/9 serotype by the University of North Carolina 81 Vector Core (Chapel Hill, NC) and have been previously described (Zhang et al., 2007; Delevich 82 et al., 2015) . All viral vectors were stored in aliquots at -80°C until use. 83
Stereotaxic surgery 84
Mice aged postnatal day 40 to 56 (P40-P56) were used for all surgeries. Unilateral viral 85 injections were performed using previously described procedures (Li et al., 2013) at the 86 following stereotaxic coordinates: MD, -1.58 mm from Bregma, 0.44 mm lateral from midline, 87 and 3.20 mm vertical from cortical surface; dorsal mPFC: 1.94 mm from Bregma, 0.34 mm 88 lateral from midline, and 0.70 mm vertical from cortical surface. Surgical procedures were 89 standardized to minimize the variability of AAV injections. To ensure minimal leak into 90 surrounding brain areas, injection pipettes remained in the brain for ~5 min post-injection before 91 being slowly withdrawn. The final volume for AAV-CAG-ChR2(H134R)-YFP injected into MD 92 was 0.3-0.35 l, and for AAV-eF1a-DIO-ChR2(H134R)-YFP injected into dorsal mPFC was 0.5 93 l. The titer for the viruses was ~10 12 viral particles/ml. For experiments in which mPFC 94 inhibitory interneurons were optogenetically stimulated (Figure 2) mice were injected at P56 and 95 ~2 weeks were allowed for viral expression before recording. For experiments in which MD 96 axons within mPFC were optogenetically stimulated (Figures 3 & 5) mice were injected at P40-97 45 and ~4 weeks were allowed for viral expression before recording. For each of these 98 experiments, littermates were injected and recorded at the same age to control for expression 99 duration between genotypes. 100 101 Electrophysiology 102
Mice were anaesthetized with isoflurane and decapitated, whereupon brains were quickly 103 removed and immersed in ice-cold dissection buffer (110.0 mM choline chloride, 25.0 mM 104 6 NaHCO 3 , 1.25 mM NaH 2 PO 4 , 2.5 mM KCl, 0.5 mM CaCl 2 , 7.0 mM MgCl 2 , 25.0 mM glucose, 105 11.6 mM ascorbic acid and 3.1mM pyruvic acid, gassed with 95% O 2 and 5% CO 2 ). Coronal 106 slices (300 μm in thickness) containing mPFC were cut in dissection buffer using a HM650 107 Vibrating Microtome (Thermo Fisher Scientific), and were subsequently transferred to a 108 chamber containing artificial cerebrospinal fluid (ACSF) (118 mM NaCl, 2.5 mM KCl, 26.2 mM 109 NaHCO 3 , 1 mM NaH 2 PO 4 , 20 mM glucose, 2 mM MgCl 2 and 2 mM CaCl 2 , at 34 °C, pH 7.4, 110 gassed with 95% O 2 and 5% CO 2 ). After ~30 min recovery time, slices were transferred to room 111 temperature and were constantly perfused with ACSF. 112 The internal solution for voltage-clamp experiments contained 140 mM potassium 113 gluconate, 10 mM HEPES, 2 mM MgCl 2 , 0.05 mM CaCl 2 , 4 mM MgATP, 0.4 mM Na 3 GTP, 10 114 mM Na 2 -Phosphocreatine, 10 mM BAPTA, and 6 mM QX-314 (pH 7.25, 290 mOsm). 115 Electrophysiological data were acquired using pCLAMP 10 software (Molecular Devices). 116 mIPSCs were recorded in the presence of tetrodotoxin (1 μM), APV (100 μM), and CNQX (5 117 μM). mEPSCs were recorded in the presence of tetrodotoxin (1 μM) and picrotoxin (100 μM). 118
Data were analyzed using Mini Analysis Program (Synaptosoft). For the mIPSCs and mEPSCs, 119 we analyzed the first 300 and 250 events, respectively, for each neuron. The parameters for 120 detecting mini events were kept consistent across neurons, and data were quantified blindly 121 with regard to the genotypes. 122 To evoke synaptic transmission by activating ChR2, we used a single-wavelength LED 123 system ( = 470 nm, CoolLED.com) connected to the epifluorescence port of the Olympus BX51 124 microscope. To restrict the size of the light beam for focal stimulation, a built-in shutter along the 125 light path in the BX51 microscope was used. Light pulses of 0.5-1 ms triggered by a TTL 126 (transistor-transistor logic) signal from the Clampex software (Molecular Devices) were used to 127 evoke synaptic transmission. The light intensity at the sample was ~0.8 mW/mm 2 . 128 Electrophysiological data were acquired and analyzed using pCLAMP 10 software (Molecular 129 Devices). IPSCs were recorded at 0 mV holding potential in the presence of 5 μM CNQX and 7 100 μM AP-5. Light pulses were delivered once every 10 seconds, and a minimum of 30 trials 131 were collected. In paired-pulse recordings, 2 light pulses separated by 50, 100, or 150 ms were 132 delivered. In cases that the first IPSC did not fully decay to baseline before the onset of the 133 second IPSC, the baseline of the second IPSC was corrected before the peak was measured. 134 To measure the kinetics of the IPSCs, averaged sweeps collected at the 150 ms interval were 135 normalized, and the decay time constant and half-width were measured using automated 136 procedures in the AxoGraph X 1.5.4 software. 137
To determine IPSC reversal potential (E IPSC ), IPSCs were recorded at varying holding 138 potentials (20 mV steps) in the presence of CNQX (5 μM) and APV (100 μM) to block AMPA 139 receptors and NMDA receptors, respectively. IPSC amplitude was measured, and a linear 140 regression was used to calculate the best-fit line, and the x-intercept was used as the E IPSC . 141 Under our recording conditions, the E IPSC was ~ -60 mV. Therefore, in the excitation/inhibition 142 ratio (E/I) experiments, we recorded EPSCs at -60 mV and IPSCs at 0 mV holding potential. 143
The only drug used for the E/I experiments was APV (100 μM). In these experiments we used 144 the same light intensity for evoking both IPSCs and EPSCs. In addition, we used similar 145 stimulation regime for WT and Disc1 LI mice, such that the peak amplitudes of IPSCs are 146 comparable between genotypes. 147 For the experiments in which we optogenetically stimulated the MD axons in the mPFC, 148 mice were excluded if the extent of infection in the MD was too large and leaked into 149 surrounding brain regions. Rodent MD lacks interneurons; therefore all ChR2 infected neurons 150 are expected to be relay projection neurons (Kuroda et al., 1998) . 151 The latency and 10-90% rise-time of EPSCs and IPSCs were calculated from either the 152 averaged trace or individual sweeps for each cell using automated procedures in the AxoGraph 153 X 1.5.4 software. ESPC and IPSC onset latency was calculated as the time from stimulation 154 onset to 10% rise time, with EPSC-IPSC delay calculated as the difference. The 10% rise time 155 has been reported to be a more reliable measure of delay to onset, as it minimizes the 156 8 contribution of EPSC and IPSC rise time differences that are reflected in the time to peak 157 (Mittmann et al., 2005) . Some of the control data from WT mice used for comparing with Disc1 158 LI mice (appearing in Fig. 3 , 4) were previously reported in Fig. 1 , 2, and 4 of (Delevich et al., 159 2015) . 160
Data analysis and statistics 161
All statistical tests were performed using Origin 9.0 (Origin-Lab, Northampton, MA) or 162 GraphPad Prism 6.0 (GraphPad Software, La Jolla, California) software. All data were tested for 163 normality using the D'Agostino-Pearson omnibus normality test to guide the selection of 164 parametric or non-parametric statistical tests. Data are presented as mean ± s.e.m. or median ± 165 interquartile range as indicated. For parametric data, a two-tailed t test or two-way ANOVA was 166 used, with a post hoc Sidak's test for multiple comparisons. For non-parametric data, a two-167 tailed Mann-Whitney U test was used. P < 0.05 was considered significant. A summary of the 168 statistical analyses performed can be found in Table 1 . 169
170

RESULTS 171
Inhibitory synaptic transmission is impaired in adult Disc1 LI mice 172
As a first estimation of inhibitory drive in the mPFC, we recorded mIPSCs onto L2/3 PNs 173 in the dorsal anterior cingulate cortex (dACC) subregion of the mPFC in adult mice (postnatal 174 day (P) 70). We found that compared with wild-type (WT) littermates, Disc1 LI mice had 175 significantly reduced mIPSC frequency (WT, 3.75 ± 3.25 Hz, n = 27 cells, N= 6; Disc1 LI, 2.27 ± 176 2.72 Hz, n = 29 cells, N=5; U = 217.0, a P < 0.01, Mann-Whitney U test), but not amplitude (WT, 177 12.5 ± 2.48 pA, n = 29 cells, N= 6; Disc1 LI, 12.52 ± 1.51 pA, n = 27 cells, N=5; U = 351.0, b P = 178 0.51, Mann-Whitney U test) ( Fig. 1A-C ). The two groups did not differ in measures of miniature 179 excitatory postsynaptic currents (mEPSC) (frequency: WT, 3.47 ± 1.97 Hz, n = 23 cells, N=4; 180 Disc1 LI, 2.79 ± 2.4 Hz, n = 20 cells, N=5; U = 173.0, c P = 0.17, Mann-Whitney U test; 181 amplitude: WT, 8.91 ± 0.18 pA; Disc1 LI, 8.99 ± 0.37 pA, t (41) = 0.18, d P = 0.86, t-test) ( Fig. 1D -182 9 F). Notably, we found that the frequency (but not amplitude) of mIPSCs recorded from dACC 183 L2/3 PNs in Disc1 LI mice was lower than their WT littermates at preweanling (~P15) age 184 amplitude (amplitude: WT, n = 44 cells; Disc1 LI, n = 26 cells; e P = 0.12, t test; frequency: WT, n 185 = 44 cells; Disc1 LI, n = 26 cells; f P < 0.05, Mann-Whitney U test) ( Fig. 1G-I) . These data 186 indicate that the inhibitory synaptic transmission is selectively impaired in the mPFC of Disc1 LI 187 mice, and that this impairment manifests early in postnatal development. 188 ChR2(H134R)-YFP). After viral expression had reached sufficient levels, we prepared acute 197 brain slices from these mice and recorded from mPFC L2/3 PNs light-evoked IPSCs ( Fig. 2A , 198 D). We used paired light pulses (pulse duration 1 ms) with an inter-pulse-interval of 50, 100, or 199 150 ms, and measured the ratio of the peak amplitude of the second IPSC over that of the first 200 (IPSC 2 /IPSC 1 ), also known as paired-pulse ratio (PPR) ( Fig. 2B , E). A similar technique has 201 previously been used to interrogate presynaptic GABA release from PV interneurons (Chu et al., 202 2012). 203 We found that the PPR of GABAergic transmission between PV INs and L2/3 PNs was 204 significantly increased in the Disc1 LI mice compared with their WT littermates at the 50 and 100 205 ms inter-pulse-intervals (WT, n = 13 cells; Disc1 LI, n = 10 cells; interval: F(2, 42) = 6.77, g P < 206 0.01; genotype: F(1, 21) = 10.77, P < 0.01; interaction: F(2, 42) = 3.92, P < 0.05; two-way 207 repeated-measures (RM) ANOVA followed by Sidak's tests) ( Fig. 2C ), suggesting that GABA 208 10 release from PV INs is impaired. In contrast, the PPR of GABAergic synaptic transmission from 209 SOM INs to L2/3 PNs did not differ between genotypes (WT, n = 15 cells, Disc1 LI, n = 12 cells; 210 interval: F(2, 50) = 24.88, h P < 0.0001; genotype: F(1, 25) = 1.64, P = 0.21; interaction F(2, 50) 211 = 0.47, P = 0.63, two-way RM ANOVA) ( Fig. 2F ). SOM-evoked IPSCs displayed significantly 212 slower decay kinetics than PV-evoked IPSCs (Fig. 2G, H (Fig. 2) , we reasoned that FFI in the MD-mPFC circuit is affected in 228 these mice. To test this hypothesis, we injected the MD of Disc1 LI mice and their WT 229 littermates with AAV-ChR2(H134R)-YFP. After viral expression reached sufficient levels we 230 used these mice to prepare acute brain slices, in which we recorded both excitatory and 231 inhibitory synaptic transmission onto dACC L3 PNs in response to optogenetic stimulation of 232 MD axons (Fig. 3A, B ). 233 11 Brief (0.5 ms) light stimulation evoked monosynaptic EPSCs and disynaptic IPSCs in L3 234 PNs in the dorsal mPFC ( Fig. 3C ) (and see (Delevich et al., 2015) ). We found that the 235 contribution of inhibitory synaptic transmission to total synaptic inputs -measured as 236 IPSC peak /(IPSC peak +EPSC peak ), or I peak /(I peak +E peak ) -was significantly lower in Disc1 LI mice than 237 in WT mice when comparing the means of the two groups of animals (Disc1 LI, 0.52 ± 0.03, N = 238 11 mice; WT, 0.70 ± 0.02, N = 14 mice; t (23) = 5.73, j P < 0.0001, t test) ( Fig. 3 D) , or the means 239 of the two groups of neurons (Disc1 LI, 0.60 ± 0.03; n = 30 cells, WT, 0.70 ± 0.02, n = 40 cells; 240 t (68) = 3.17, k P < 0.01, t test) ( Fig. 3 E) . In addition, the slope of a linear regression describing the 241 relationship between IPSCs and EPSCs of individual neurons in the Disc1 LI mice was 242 significantly lower than that in the WT (Fig. 3F ). The latencies ( Fig. 3G-I) and kinetics of the 243 EPSCs ( Fig. 3J-K) and IPSCs (Fig. 3L-M) in Disc1 LI mice were similar to those in WT mice. 244 These results together indicate that Disc1 LI is associated with reduced MD-driven FFI in the 245 mPFC. 246 INs in the context of Disc1 LI. We found that mEPSC amplitude and frequency onto mPFC PV 258
Altered presynaptic function of PV interneurons in
Spontaneous excitatory synaptic transmission onto PV interneurons and their intrinsic
INs was consistent between genotypes (amplitude: WT, 12.39 ± 0.40 pA; Disc1 LI, 13.48 ± 0.45 259 12 pA, n= 20, 23 cells/genotype, N=4, 4 mice/genotype; t (41) = 1.78, l P= 0.08; frequency: WT, 6.99 ± 260 0.74 Hz; Disc1 LI, 6.55 ± 0.69 Hz, t (41) = 0.53, m P=0.60) (Fig. 4A-B ). Next, we examined the 261 intrinsic properties of PV INs in WT and Disc1 LI mice and found no significant differences 262 between genotypes ( Fig. 4C-H) , including minimum current injection required to elicit spiking 263 (WT, 142.3 ± 12.67 pA; Disc1 LI, 119.2 ± 14.3 pA, t (24) = 1.21, n P= 0.24) ( Fig. 4G ) or maximum 264 firing rate (WT, 88.92 ± 3.9 Hz; Disc1 LI, 88.92 ± 6.78 Hz, t (24) = 0, o P > 0.99) (Fig. 4H) . These 265 results suggest that neither intrinsic excitability of prefrontal PV INs nor spontaneous 266 glutamatergic transmission onto them is grossly perturbed in Disc1 LI mice. 267
Enhanced input but reduced output of PV interneurons in Disc1 LI mice 268
We next examined recruitment of mPFC PV INs specifically within the MD-mPFC circuit 269 to determine whether reduced excitatory drive could account for the observed reduction in FFI in 270 Disc1 LI mice. We recorded evoked EPSCs from PV IN and PN pairs in the mPFC in response 271 to optogenetic stimulation of MD axons (Fig. 5A ). We found that in WT mice, amplitudes of pairs, W = -83, q P < 0.01 Wilcoxon matched-pairs signed rank test) ( Fig 5B, C) . These data 277 suggest that MD excitatory drive onto PV INs is enhanced relative to L2/3 PNs in the mPFC of 278 Disc1 LI mice. Therefore, reduced excitatory synaptic strength onto PV INs doesn't account for 279 the decrease in FFI in the MD-mPFC circuit in Disc1 LI mice compared to WT (Fig. 3) . 280 Next, we probed presynaptic GABA release from PV cells within the MD-mFPC circuit, 281 by optogenetically stimulating the MD axons (see the recording configuration in Fig. 3A & B) and 282 measuring the PPR of MD-driven FFI onto mPFC PNs (Fig. 5D ). Notably, we found that PPR of 283 was significantly higher in Disc1 LI mice than in WT mice (WT: 0.0 ± 0.1, n = 24 cells, N= 10; 284 Disc1 LI: 0.24 ± 0.34, n = 17 cells, N=6; U = 62, r P = 0.0001, two-tailed Mann Whitney U test) 285 13 ( Fig. 5D, E) , mirroring the increase in PPR we observed when directly activating PV INs (Fig.  286 2C). In order to reduce variability in measuring the PPR, we set the light-stimulation such that 287 there was no difference between genotypes in the average amplitude of the first evoked IPSCs 288 (WT, 439.3 ± 41.31 pA, n = 24 cells, N=10; Disc1 LI, 367.1 ± 46.26 pA, n = 17 cells, N=6; t (39) = 289 1.152, s P = 0.256, unpaired t test) ( Fig. 5F ). Finally, we examined the relationship between PPR 290 of MD-driven FFI and E-I ratio of MD-driven synaptic currents onto PNs. We found that there 291 was a significant inverse correlation between FFI PPR and I peak /(I peak +E peak ) within PNs from 292 Disc1 LI mice but not WT mice (Fig. 5G ). Together, our data suggest that in Disc1 LI mice, 293 GABA release from prefrontal PV INs is reduced, leading to decreased FFI in the MD-mPFC 294 circuit. 295
Discussion 296
Perturbation of the multifunctional scaffolding protein DISC1 is linked to a range of 297 behavioral phenotypes that are associated with major psychiatric disorders (Brandon and Sawa, 298 2011). These findings highlight DISC1 as a promising molecular lead to investigate the 299 molecular pathways and neural circuits that underlie major mental illnesses (Niwa et al., 2016) . 300 Here, we used the Disc1 LI mouse model to investigate the function of mPFC circuits that may 301 be particularly relevant to the cognitive symptoms of psychiatric disorders. We found that Disc1 302 LI exhibited elevated E-I ratio, measured as a reduction of spontaneous inhibitory transmission 303 onto L2/3 PNs in mPFC and decreased FFI onto L2/3 PNs in the MD-mPFC circuit. Several 304 lines of evidence suggest that this effect can be accounted for by a reduction in GABA release 305 from PV INs in the mPFC 1) mIPSC frequency was significantly reduced onto L2/3 PNs in Disc1 306 LI mice, consistent with a reduction in presynaptic release probability; 2) the PPR of (Delevich et al., 2015) . 392 Interestingly, chemogenetic excitation of mPFC PV INs has been shown to rescue cognitive 393 deficits induced by chemogenetic inhibition of MD (Ferguson and Gao, 2018b) . 394 Our findings extend data suggesting that MD, via its projections to PV INs, is a key 395 regulator of E-I balance that underpins prefrontal cortex circuit function. We demonstrate that 396 reduced DISC1 expression, a key molecular candidate to study biology relevant to behavioral 397 constructs related to several psychiatric disorders, leads to elevated E-I balance in the MD-398 mPFC thalamofrontal circuit. Given that few treatment options exist to address the cognitive 399 symptoms of psychiatric disorders, efforts towards understanding the cellular and molecular 400 mechanisms underlying abnormal thalamofrontal functional connectivity may yield therapies that 401 will improve patient outcomes. 402
403
References: 404 405 Alcaraz 
